Low may get lower..
Who know US may drops an atomic bomb to the financial market this coming friday of  no breakthrough on the debt ceiling talks.
Yellen warning on ceiling debt financial catastrophe!
Who know US may drops an atomic bomb to the financial market this coming friday of  no breakthrough on the debt ceiling talks.
Yellen warning on ceiling debt financial catastrophe!
tbooncho888 ( Date: 11-May-2023 04:44) Posted:
|
still waiting to enter on day 4 today at lower price, come lower pls.
joined the VO3 party yesterday :)))

Sgvale ( Date: 10-May-2023 09:44) Posted:
|
Good entry now
already xd, not cd
pity those who bought for div..
earn 50c
lose more than double
worth it? your guess is as good as mine..
pity those who bought for div..
earn 50c
lose more than double
worth it? your guess is as good as mine..
mchua71 ( Date: 09-May-2023 18:04) Posted:
|
drop is so controlled to makan by the BB....drop faster leh...
Can' t time the bottom.
If have extra cash just nimble to keep and collect dividends.
If no extra cash better to skip. Yes, indeed cheap can always go cheaper.
For me, yup. I have extras ) guess what I' m doing.
If have extra cash just nimble to keep and collect dividends.
If no extra cash better to skip. Yes, indeed cheap can always go cheaper.
For me, yup. I have extras ) guess what I' m doing.
tongphlp ( Date: 09-May-2023 15:03) Posted:
|
fire sale...cheap can be cheaper
MambaFinancial89 ( Date: 09-May-2023 15:02) Posted:
|
Venture Corp is officially on sale! 
that said, it needs to have a leap of faith :)
michaeltan ( Date: 09-May-2023 11:39) Posted:
|
The faith of Venture is determined by BB.
 
 
tongphlp ( Date: 09-May-2023 09:52) Posted:
|
come lower pls, q to buy bargain
nothing new. hopeless stock.
Joelton ( Date: 09-May-2023 09:31) Posted:
|
Venture shares fall on Monday after Q1 results release
 
SHARES of Venture Corporation : V03 -6.51% fell on Monday (May 8) morning after the technology company last week reported a year-on-year decline in its profit for the first fiscal quarter.
 
As at 9.27 am, the counter had shed S$1.04 or 6.1 per cent to S$16.02 from the previous week&rsquo s closing price of S$17.06. This was S$0.54 or 3.3 per cent below Friday&rsquo s adjusted close of S$16.56, factoring in a dividend of S$0.50 per share. The company began trading ex-dividend on Monday morning.
 
It later recovered to trade at S$16.10, down S$0.96 or 5.6 per cent, as at 10.37 am. 
 
No married deals were recorded in early trade, ShareInvestor data showed. 
 
The share price movement occurred after the company on Friday reported that Q1 net profit was down 12.4 per cent year on year to S$73.6 million.
 
Analysts lowered their target prices for Venture after its Q1 earnings underperformed estimates. 
 
Maybank Securities maintained a &ldquo hold&rdquo call for the counter but lowered its target price to S$16.50, from S$17.32. This came after the brokerage downgraded Venture to &ldquo hold&rdquo from &ldquo buy&rdquo last month. 
 
RHB kept its &ldquo buy&rdquo call and cut its target price to S$19.36. Similarly, CGS-CIMB reiterated &ldquo add&rdquo for Venture and reduced its target price to S$18.11. 
 
UOB Kay Hian (UOBKH) downgraded Venture to &ldquo hold&rdquo with a lowered target price of S$16.99, though it noted that the stock currently offers a &ldquo decent&rdquo dividend yield of about 4.4 per cent. 
 
DBS Group Research also downgraded the stock to &ldquo hold&rdquo , and lowered its target price to S$18.10.
 
Based on the outlook of Venture&rsquo s customers, near-term demand weakness is expected, said UOBKH. 
 
CGS-CIMB added that as customers delay product launches and become more cautious in their order placement, it could lead to a decline in forecast FY2023 revenue and net profit. The brokerage reduced its FY2023 to FY2025 revenue forecasts by 11.8 per cent. 
 
Despite challenging times ahead, Maybank noted that demand from Venture&rsquo s life sciences and healthcare customers remains strong. It believes new product introductions expected in the coming quarters may boost profitability. 
 
As at end-March, Venture has a net cash position of S$920 million and no debt. DBS said this would support at least a repeat of the S$0.75 distribution per share in FY2022 for the current financial year. 
 
RHB was positive on the stock, although Venture&rsquo s Q1 performance was disappointing. The brokerage anticipates global economic recovery and growth to begin by the summer of 2023. 
 
&ldquo This should strengthen customer demand and spur more aggressive programme rollouts over the longer term,&rdquo it added. 
 
Overall, DBS and Maybank were optimistic about the company&rsquo s long-term prospects. 
 
&ldquo We remain positive on Venture&rsquo s ability to monetise its unique offerings and differentiating capabilities,&rdquo noted DBS.
Looking to buy at ard 15.36....
Doubt it, highly cyclical play and we are in the midst of global recessionary pressures. Stock takes a hit accordingly. Recall during the peaks of 2017/2018 the counter approached $30 when the global economy was roaring. Feel that it is time to buy if you take a long-term view as the company is supported by a very robust balance sheet and should maintain dividends. My personal opinion only and every individual investor operates on different time horizons.
Buffett:  " The stock market is a device for transferring money from the impatient to the patient."
Buffett:  " The stock market is a device for transferring money from the impatient to the patient."
tongphlp ( Date: 08-May-2023 11:09) Posted:
|
looks like Venture being a penny stock is materialising..
tongphlp ( Date: 12-Apr-2023 14:17) Posted:
|
who were the ones taken in by CIMB who put a TP of $20?
 
 
MambaFinancial89 ( Date: 08-May-2023 09:29) Posted:
|
CGS-CIMB SIN: Venture Corporation - FY23F net profit likely to decline
 
Ventures 1Q23 revenue fell 7.6% yoy (due to softer consumer demand) to S$821.7m, 10.0% below our S$910.4m forecast.
 
1Q23 net profit fell 12.4% yoy to S$73.6m, 6.0% below our S$78.2m forecast. 1Q23 net profit margin held at 9.0% on cost management.
 
Management expects near-term demand weakness, leading us to revise our FY23-25F forecasts downwards. TP is reduced to S$18.11 reiterate Add
https://rfs.cgs-cimb.com/api/download?file=c76f1134-bce9-4db4-8922-60ac039fe3b8
 
Ventures 1Q23 revenue fell 7.6% yoy (due to softer consumer demand) to S$821.7m, 10.0% below our S$910.4m forecast.
 
1Q23 net profit fell 12.4% yoy to S$73.6m, 6.0% below our S$78.2m forecast. 1Q23 net profit margin held at 9.0% on cost management.
 
Management expects near-term demand weakness, leading us to revise our FY23-25F forecasts downwards. TP is reduced to S$18.11 reiterate Add
https://rfs.cgs-cimb.com/api/download?file=c76f1134-bce9-4db4-8922-60ac039fe3b8
Venture has been hopeless for quite a while now...should seek for management and board renewal..
TodaySgCny ( Date: 06-May-2023 10:31) Posted:
|